Coya Therapeutics (COYA) EBIT Margin (2023 - 2025)
Historic EBIT Margin for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 68.26%.
- Coya Therapeutics' EBIT Margin changed N/A to 68.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 516.7%, marking a year-over-year decrease of 3978600.0%. This contributed to the annual value of 485.35% for FY2024, which is 3536800.0% down from last year.
- According to the latest figures from Q3 2025, Coya Therapeutics' EBIT Margin is 68.26%.
- In the past 5 years, Coya Therapeutics' EBIT Margin registered a high of 30.24% during Q4 2023, and its lowest value of 209031.51% during Q4 2024.
- Moreover, its 3-year median value for EBIT Margin was 2976.89% (2025), whereas its average is 31483.46%.
- Its EBIT Margin has fluctuated over the past 5 years, first crashed by 2000000000bps in 2024, then surged by 13459500bps in 2025.
- Over the past 3 years, Coya Therapeutics' EBIT Margin (Quarter) stood at 30.24% in 2023, then plummeted by -691308bps to 209031.51% in 2024, then surged by 100bps to 68.26% in 2025.
- Its last three reported values are 68.26% in Q3 2025, 3920.47% for Q2 2025, and 2976.89% during Q1 2025.